News and public relations

News and public relations

Clariness strengthens its European patient access with acquisition of health platform Mondosano

News | 11 March 2025

Clariness strengthens its European patient access with acquisition of health platform Mondosano

Boehringer Ingelheim RCV extend partnership with Clariness until 2028

News | 18 November 2024

Boehringer Ingelheim RCV extend partnership with Clariness until 2028

Clariness launches new Site Contact Center, boosting site support efficiencies by 4x 

News | 19 September 2024

Clariness launches new Site Contact Center, boosting site support efficiencies by 4x 

Boehringer Ingelheim RCV & Clariness expand partnership to bring 20+ studies to additional markets

News | 29 November 2023

Boehringer Ingelheim RCV & Clariness expand partnership to bring 20+ studies to additional markets

Clariness sets a new industry standard of >90% patient reachability with the launch of ClinLife® Connect

News | 22 November 2023

Clariness sets a new industry standard of >90% patient reachability with the launch of ClinLife® Connect

Clariness delivers more than 50,000 patient data points to drive YPrime’s customer experience

News | 24 April 2023

Clariness delivers more than 50,000 patient data points to drive YPrime’s customer experience

Clariness supports Bayer Pharma AG’s new 360° study review process

News | 25 August 2022

Clariness supports Bayer Pharma AG’s new 360° study review process

Klinische Forschung Berlin adds more studies to Clariness’ innovative patient recruitment platform, ClinLife Registry

News | 11 July 2022

Klinische Forschung Berlin adds more studies to Clariness’ innovative patient recruitment platform, ClinLife Registry

Clariness partners with an innovative asthma app focused on environmental triggers, DailyBreath, to bring more trials to patients with respiratory conditions

News | 08 July 2022

Clariness partners with an innovative asthma app focused on environmental triggers, DailyBreath, to bring more trials to patients with respiratory conditions

Phase II study for Sjögren’s syndrome drug: Cooperation between SERVIER Than and Clariness

News | 12 April 2022

Phase II study for Sjögren’s syndrome drug: Cooperation between SERVIER Than and Clariness

Clariness and Boehringer Ingelheim RCV partner to bring new ClinLife services to Poland and Austria

News | 08 December 2021

Clariness and Boehringer Ingelheim RCV partner to bring new ClinLife services to Poland and Austria

Clariness to advance digital recruitment in new multi-year partnership with Boehringer Ingelheim in Germany

News | 29 November 2021

Clariness to advance digital recruitment in new multi-year partnership with Boehringer Ingelheim in Germany

Clariness supports Covid-19 studies

News | 26 October 2020

Clariness supports Covid-19 studies